$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 2 3 4 5 6 7 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 176.61 | 660 | 116,563 | 7,654 | 8.3 K to 7.7 K (-7.94 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,495 | 0 | 8,314 | 6.8 K to 8.3 K (+21.92 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.13 | 1,365 | 239,057 | 16,469 | 17.8 K to 16.5 K (-7.65 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,495 | 0 | 17,834 | 16.3 K to 17.8 K (+9.15 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | M | 46.83 | 4,500 | 210,735 | 0 | |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.61 | 660 | 116,563 | 4,950 | 5.6 K to 5 K (-11.76 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.03 | 3,437 | 605,015 | 5,610 | 9 K to 5.6 K (-37.99 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.31 | 3,542 | 624,481 | 9,047 | 12.6 K to 9 K (-28.14 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,495 | 0 | 12,589 | 11.1 K to 12.6 K (+13.48 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 176.15 | 9,000 | 1,585,341 | 11,094 | 20.1 K to 11.1 K (-44.79 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Buy | M | 46.83 | 4,500 | 210,735 | 20,094 | 15.6 K to 20.1 K (+28.86 %) |
Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Buy | M | 81.76 | 4,500 | 367,920 | 15,594 | 11.1 K to 15.6 K (+40.56 %) |
Aug 03 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 173.90 | 1,600 | 278,240 | 282,515 | 284.1 K to 282.5 K (-0.56 %) |
Jul 18 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 176.06 | 700 | 123,242 | 34,868 | 35.6 K to 34.9 K (-1.97 %) |
Jul 17 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 179.15 | 200 | 35,830 | 25,772 | 26 K to 25.8 K (-0.77 %) |
Jul 05 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.81 | 1,600 | 273,296 | 284,115 | 285.7 K to 284.1 K (-0.56 %) |
Jun 19 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 176.99 | 700 | 123,893 | 35,568 | 36.3 K to 35.6 K (-1.93 %) |
Jun 18 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 176.53 | 200 | 35,306 | 25,972 | 26.2 K to 26 K (-0.76 %) |
Jun 07 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 172.54 | 123 | 21,222 | 26,172 | 26.3 K to 26.2 K (-0.47 %) |
Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | M | 58.72 | 5,000 | 293,600 | 12,192 | |
Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 170.04 | 5,000 | 850,212 | 36,268 | 41.3 K to 36.3 K (-12.12 %) |
Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Buy | M | 58.72 | 5,000 | 293,600 | 41,268 | 36.3 K to 41.3 K (+13.79 %) |
Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 168.01 | 4,000 | 672,040 | 285,715 | 289.7 K to 285.7 K (-1.38 %) |
Jun 05 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.00 | 3,000 | 510,000 | 289,715 | 292.7 K to 289.7 K (-1.02 %) |
May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 164.64 | 1,420 | 233,789 | 36,203 | 37.6 K to 36.2 K (-3.77 %) |
May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 166.00 | 842 | 139,772 | 37,623 | 38.5 K to 37.6 K (-2.19 %) |
May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 164.64 | 1,420 | 233,789 | 36,203 | 37.6 K to 36.2 K (-3.77 %) |
May 16 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 166.00 | 842 | 139,772 | 37,623 | 38.5 K to 37.6 K (-2.19 %) |
May 15 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 165.01 | 54 | 8,910 | 15,757 | 15.8 K to 15.8 K (-0.34 %) |
May 15 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 165.00 | 3,706 | 611,490 | 15,811 | 19.5 K to 15.8 K (-18.99 %) |
May 15 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 164.68 | 200 | 32,936 | 26,122 | 26.3 K to 26.1 K (-0.76 %) |
May 09 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 147.03 | 1,159 | 170,408 | 26,322 | 27.5 K to 26.3 K (-4.22 %) |
Apr 18 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 156.01 | 700 | 109,207 | 38,465 | 39.2 K to 38.5 K (-1.79 %) |
Apr 13 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 157.49 | 200 | 31,498 | 27,481 | 27.7 K to 27.5 K (-0.72 %) |
Apr 12 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Sell | S | 155.00 | 3,899 | 604,345 | 19,517 | 23.4 K to 19.5 K (-16.65 %) |
Apr 04 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.01 | 1,000 | 150,010 | 293,542 | 294.5 K to 293.5 K (-0.34 %) |
Mar 19 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 151.22 | 700 | 105,854 | 39,165 | 39.9 K to 39.2 K (-1.76 %) |
Mar 16 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 151.12 | 200 | 30,224 | 27,681 | 27.9 K to 27.7 K (-0.72 %) |
Mar 13 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 1,000 | 150,000 | 294,542 | 295.5 K to 294.5 K (-0.34 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 143.39 | 4,288 | 614,856 | 295,542 | 299.8 K to 295.5 K (-1.43 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Payment of Exercise | F | 143.39 | 1,239 | 177,660 | 38,247 | 39.5 K to 38.2 K (-3.14 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Payment of Exercise | F | 143.39 | 614 | 88,041 | 22,048 | 22.7 K to 22 K (-2.71 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 143.39 | 648 | 92,917 | 27,881 | 28.5 K to 27.9 K (-2.27 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Payment of Exercise | F | 143.39 | 648 | 92,917 | 28,474 | 29.1 K to 28.5 K (-2.23 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 141.47 | 594 | 84,030 | 18,641 | 19.2 K to 18.6 K (-3.09 %) |
Mar 07 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 143.39 | 302 | 43,304 | 23,416 | 23.7 K to 23.4 K (-1.27 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.67 | 22,790 | 3,205,869 | 22,790 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Option Exercise | A | 140.67 | 710 | 99,876 | 710 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Grant | A | 0.00 | 9,400 | 0 | 42,365 | 33 K to 42.4 K (+28.52 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.67 | 7,319 | 1,029,564 | 7,319 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Option Exercise | A | 140.67 | 681 | 95,796 | 681 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Grant | A | 0.00 | 3,200 | 0 | 23,718 | 20.5 K to 23.7 K (+15.60 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Option Exercise | A | 140.67 | 9,000 | 1,266,030 | 9,000 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 139.63 | 352 | 49,148 | 19,235 | 19.6 K to 19.2 K (-1.80 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 139.62 | 525 | 73,298 | 19,587 | 20.1 K to 19.6 K (-2.61 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Grant | A | 0.00 | 3,600 | 0 | 20,112 | 16.5 K to 20.1 K (+21.80 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Option Exercise | A | 140.67 | 42,160 | 5,930,647 | 42,160 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Option Exercise | A | 140.67 | 2,840 | 399,503 | 2,840 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Grant | A | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Option Exercise | A | 140.67 | 19,290 | 2,713,524 | 19,290 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Option Exercise | A | 140.67 | 710 | 99,876 | 710 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | EVP, R&D and CMO | Grant | A | 0.00 | 8,000 | 0 | 29,122 | 21.1 K to 29.1 K (+37.88 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Option Exercise | A | 140.67 | 19,290 | 2,713,524 | 19,290 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Option Exercise | A | 140.67 | 710 | 99,876 | 710 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Grant | A | 0.00 | 8,000 | 0 | 28,529 | 20.5 K to 28.5 K (+38.97 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Option Exercise | A | 140.67 | 10,000 | 1,406,700 | 10,000 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Grant | A | 0.00 | 4,000 | 0 | 22,662 | 18.7 K to 22.7 K (+21.43 %) |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 140.67 | 22,790 | 3,205,869 | 22,790 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | A | 140.67 | 710 | 99,876 | 710 | |
Mar 05 2018 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Grant | A | 0.00 | 9,400 | 0 | 39,486 | 30.1 K to 39.5 K (+31.24 %) |
Feb 28 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 143.80 | 324 | 46,591 | 20,518 | 20.8 K to 20.5 K (-1.55 %) |
Feb 28 2018 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | SVP, Finance & PAO | Payment of Exercise | F | 147.44 | 537 | 79,175 | 20,842 | 21.4 K to 20.8 K (-2.51 %) |
Feb 16 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 139.99 | 200 | 27,998 | 21,469 | 21.7 K to 21.5 K (-0.92 %) |
Jan 18 2018 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Sell | S | 152.16 | 700 | 106,512 | 38,959 | 39.7 K to 39 K (-1.77 %) |
Jan 17 2018 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 148.65 | 200 | 29,730 | 21,669 | 21.9 K to 21.7 K (-0.91 %) |
Jan 17 2018 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 3,000 | 450,000 | 273,737 | 276.7 K to 273.7 K (-1.08 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 139.15 | 200 | 27,830 | 21,869 | 22.1 K to 21.9 K (-0.91 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | M | 59.13 | 1,691 | 99,989 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | M | 46.83 | 4,867 | 227,922 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Option Exercise | M | 8.23 | 44,200 | 363,766 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Buy | M | 59.13 | 1,691 | 99,989 | 102,821 | 101.1 K to 102.8 K (+1.67 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Buy | M | 46.83 | 4,867 | 227,922 | 101,130 | 96.3 K to 101.1 K (+5.06 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Buy | M | 8.23 | 44,200 | 363,766 | 96,263 | 52.1 K to 96.3 K (+84.90 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | M | 46.83 | 4,500 | 210,735 | 0 | |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 140.50 | 2,842 | 399,294 | 16,339 | 19.2 K to 16.3 K (-14.82 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 139.56 | 5,358 | 747,771 | 19,181 | 24.5 K to 19.2 K (-21.83 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 138.15 | 800 | 110,516 | 24,539 | 25.3 K to 24.5 K (-3.16 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 81.76 | 4,500 | 367,920 | 25,339 | 20.8 K to 25.3 K (+21.59 %) |
Dec 13 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Buy | M | 46.83 | 4,500 | 210,735 | 20,839 | 16.3 K to 20.8 K (+27.54 %) |
Nov 21 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Option Exercise | M | 46.83 | 8,000 | 374,640 | 4,500 | |
Nov 21 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Sell | S | 133.42 | 8,000 | 1,067,358 | 20,383 | 28.4 K to 20.4 K (-28.19 %) |
Nov 21 2017 | JAZZ | Jazz Pharmaceutica ... | McGill Iain | SVP, Europe & Rest ... | Buy | M | 46.83 | 8,000 | 374,640 | 28,383 | 20.4 K to 28.4 K (+39.25 %) |
Nov 21 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 133.19 | 352 | 46,883 | 1,365 | 1.7 K to 1.4 K (-20.50 %) |
Oct 04 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 1,000 | 150,000 | 276,664 | 277.7 K to 276.7 K (-0.36 %) |
Sep 13 2017 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 153.52 | 1,000 | 153,520 | 277,664 | 278.7 K to 277.7 K (-0.36 %) |
Aug 28 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 148.40 | 351 | 52,088 | 1,717 | 2.1 K to 1.7 K (-16.97 %) |
Aug 16 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 144.38 | 200 | 28,876 | 21,996 | 22.2 K to 22 K (-0.90 %) |
Aug 15 2017 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 143.30 | 1,104 | 158,203 | 16,385 | 17.5 K to 16.4 K (-6.31 %) |
Aug 15 2017 | JAZZ | Jazz Pharmaceutica ... | Treacy Paul | SVP, Technical Oper ... | Sell | S | 143.41 | 200 | 28,681 | 17,489 | 17.7 K to 17.5 K (-1.13 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 144.22 | 3 | 433 | 11,094 | 11.1 K to 11.1 K (-0.03 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 142.36 | 659 | 93,815 | 11,097 | 11.8 K to 11.1 K (-5.61 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 1,365 | 0 | 11,756 | 10.4 K to 11.8 K (+13.14 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 144.22 | 3 | 433 | 6,819 | 6.8 K to 6.8 K (-0.04 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 142.36 | 659 | 93,815 | 6,822 | 7.5 K to 6.8 K (-8.81 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 1,365 | 0 | 7,481 | 6.1 K to 7.5 K (+22.32 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Sell | S | 144.13 | 2 | 288 | 5,341 | 5.3 K to 5.3 K (-0.04 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Sell | S | 144.20 | 3 | 433 | 5,343 | 5.3 K to 5.3 K (-0.06 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Sell | S | 142.36 | 1,194 | 169,978 | 5,346 | 6.5 K to 5.3 K (-18.26 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 1,365 | 0 | 6,540 | 5.2 K to 6.5 K (+26.38 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 144.13 | 3 | 432 | 5,656 | 5.7 K to 5.7 K (-0.05 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 142.36 | 659 | 93,815 | 5,659 | 6.3 K to 5.7 K (-10.43 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,365 | 0 | 6,318 | 5 K to 6.3 K (+27.56 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 144.11 | 3 | 432 | 12,810 | 12.8 K to 12.8 K (-0.02 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 142.36 | 659 | 93,815 | 12,813 | 13.5 K to 12.8 K (-4.89 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,365 | 0 | 13,472 | 12.1 K to 13.5 K (+11.27 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 1,365 | 0 | 1,049,373 | 1 M to 1 M (+0.13 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 144.13 | 3 | 432 | 6,724 | 6.7 K to 6.7 K (-0.04 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 142.36 | 714 | 101,645 | 6,727 | 7.4 K to 6.7 K (-9.60 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 1,365 | 0 | 7,441 | 6.1 K to 7.4 K (+22.47 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 144.22 | 3 | 433 | 7,402 | 7.4 K to 7.4 K (-0.04 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 142.36 | 714 | 101,645 | 7,405 | 8.1 K to 7.4 K (-8.79 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 1,365 | 0 | 8,119 | 6.8 K to 8.1 K (+20.21 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 144.13 | 3 | 432 | 2,068 | 2.1 K to 2.1 K (-0.14 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 142.36 | 659 | 93,815 | 2,071 | 2.7 K to 2.1 K (-24.14 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 1,365 | 0 | 2,730 | 1.4 K to 2.7 K (+100.00 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 144.13 | 3 | 432 | 5,937 | 5.9 K to 5.9 K (-0.05 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 142.36 | 659 | 93,815 | 5,940 | 6.6 K to 5.9 K (-9.99 %) |
Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,365 | 0 | 6,599 | 5.2 K to 6.6 K (+26.08 %) |
Aug 09 2017 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & COO | Payment of Exercise | F | 155.56 | 978 | 152,138 | 51,985 | 53 K to 52 K (-1.85 %) |
Jul 21 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 160.00 | 4,580 | 732,800 | 32,322 | 36.9 K to 32.3 K (-12.41 %) |
Jul 18 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 154.97 | 200 | 30,994 | 22,196 | 22.4 K to 22.2 K (-0.89 %) |
Jun 26 2017 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 160.00 | 420 | 67,200 | 36,902 | 37.3 K to 36.9 K (-1.13 %) |
Jun 16 2017 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 150.65 | 200 | 30,130 | 22,223 | 22.4 K to 22.2 K (-0.89 %) |
Jun 02 2017 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 150.00 | 5,000 | 750,000 | 10,391 | 15.4 K to 10.4 K (-32.49 %) |
May 16 2017 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 153.79 | 815 | 125,339 | 39,533 | 40.3 K to 39.5 K (-2.02 %) |